A Study to Evaluate the Effects of 4 Weeks Treatment With Subcutaneous Elamipretide on Left Ventricular Function in Subjects With Stable Heart Failure With Preserved Ejection Fraction
Clinical trial NCT02814097 · COMPLETED
Trial details
- NCT number
- NCT02814097
- Sponsor
- Stealth BioTherapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-02
- Primary completion
- 2017-05-04
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.